unknown linearity [Regulatives / Guidelines]

posted by kudra23 – 2012-01-30 11:30 (5263 d 22:17 ago) – Posting: # 8016
Views: 3,077

Dear all,

There are two products (x mg and y mg capsules) for which BE study will be conducted. We want to submit one of the dosage forms as a biowaver.

Although the other criteria is all fulfilled as per the general biowaver criteria defined in the 4.1.6th article of the guideline, linearity of the active is not known. Can you please advise how to proceed?

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
239 visitors (0 registered, 239 guests [including 15 identified bots]).
Forum time: 10:48 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5